Potential Molecular Targeted Therapeutics: Role of PI3-K/Akt/mTOR Inhibition in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|16|1|29-37

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.16, Iss.1, 2016-01, pp. : 29-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: Inhibition of PI3K/Akt/mTOR Signaling by Natural Products)

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 967-970

Bentham Science Publishers

Access to resources Recommend Favorite

Butein suppresses cervical cancer growth through the PI3K/AKT/mTOR pathway

By      

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 3085-3092

Spandidos Publications

Access to resources Recommend Favorite

βhydroxyisovalerylshikonin induces human cervical cancer cell apoptosis via PI3K/AKT/mTOR signaling

By            

Oncology Letters, Vol. 10, Iss. 6, 2015-01 ,pp. : 3434-3442

Spandidos Publications

Access to resources Recommend Favorite

Inhibitors of the PI3K/Akt/mTOR Pathway: New Hope for Breast Cancer Patients

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 5, Iss. 1, 2010-01 ,pp. : 29-57

Bentham Science Publishers

Access to resources Recommend Favorite

Deregulation of PI3K/Akt/mTOR Signaling Pathways by Isoflavones and its Implication in Cancer Treatment

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 7, 2013-09 ,pp. : 1014-1024

Bentham Science Publishers

Access to resources Recommend Favorite